Infographic Brochure Index and sample pages

Industry Report

Generic and innovative drugs market in the Czech Republic

Market analysis and development forecasts for 2018-2023

This product is also available in Polish

Generic and innovative drugs market in the Czech Republic

Market analysis and development forecasts for 2018-2023

Infographic Brochure Index and sample pages
Other versions: Polish
Sector: Pharmacy and healthcare
Country: Czech Republic

This report presents an extensive study of the market for generic and innovative drugs in the Czech Republic and includes market value, historic data, and updates to key regulations on pricing and reimbursement regarding generic and innovative drugs.

Topics include profiles of top companies engaged in the manufacture of generic and innovative drugs, top-selling products in those segments. The report also provides in-depth forecasts for market development in 2018-2023 for each generic and innovative group as well as the total pharmaceutical market.

Content

What is the content of the report?

  • Key indicators for the market in the Czech Republic: value, growth dynamics, market shares of each segment, share of the pharmaceutical market held by generic and innovative drugs
  • Forecasts calculated for key indices in 2018-2023 (generic and innovative drugs, total pharmaceutical market)
  • Structure of the market, plus data that tracks recent development of each market segment
  • Leading manufacturers operating on this market, described in detailed business profiles that include operations, financial results, and plans for further growth
  • Top-selling generic and innovative drugs in the Czech Republic
  • Regulations with regard to pricing and reimbursement on the market for generic and innovative drugs in the Czech Republic
  • Patent expiry, data exclusivity rules, discussion of SPCs (supplemental protection certificates), and markup rules
  • Anticipated modifications to reimbursement policy and lists with respect to generics and innovative drugs in the Czech Republic.
Benefits

Why to buy the report?

This analysis enables readers in the Czech Republic and Central Europe to…

  • Evaluate this market, its structure and growth potential while budgeting, creating development strategy or making a decision about investing in or entering the market
  • Review and assess the competitive environment in the pharmaceutical market in the Czech Republic
  • Add or delete items to a corporate pharmaceutical product portfolio
  • Examine a wide variety of data, analysis, and forecasts for expansion on the market for generic and innovative drugs in the Czech Republic
  • Study current reimbursement procedures and plan for changes
  • Analyse the potential effects of upcoming market changes as a result of new regulations on pricing, patents, and reimbursements and market and economic trends.
Users

Who benefits from the analysis?

PMR clients that benefit from this report include managerial and operational staff of business development, sales and marketing from:

  • Manufacturers and distributors of generic and innovative drugs active in the Czech Republic
  • Businesses planning local pharma market entry
  • Agencies promoting and researching the pharmaceutical and healthcare products and services in the Czech Republic
  • Investment firms, banks and brokerage houses
  • Business consultants and market analysts, chambers of commerce, trade groups, educational institutes and government offices that analyse the pharmaceutical market in Central Europe.
Table of Contents
  • Methodology
  • Executive summary

More info

For details on price and content please call:
+48 782 011 000
or email sales@pmrcorporate.com

Other versions: Polish
Sector: Pharmacy and healthcare
Country: Czech Republic

Unlimited sharing and use of the Product inside one Organisation.

For more information please visit: mypmr.pro/terms-and-conditions

This content is available for current PMR clients. If you are a client please log-in or contact us for more information at: +48 782 011 000.

Jest to zawartość dostępna dla obecnych klientów PMR. Jeśli jesteś klientem, zaloguj się lub skontaktuj się z nami, aby uzyskać więcej informacji: +48 782 011 000.